Treatment of hypercalcaemia of malignancy with clodronate
- 31 December 1991
- Vol. 12, S19-S23
- https://doi.org/10.1016/8756-3282(91)90062-n
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Immunochemical Characterization of Circulating Parathyroid Hormone–Related Protein in Patients with Humoral Hypercalcemia of CancerNew England Journal of Medicine, 1990
- Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.Journal of Clinical Investigation, 1990
- Increased Serum Levels of a Parathyroid Hormone-like Protein in Malignancy-Associated HypercalcemiaAnnals of Internal Medicine, 1989
- Pathophysiological Aspects and Therapeutic Approaches of Tumoral Osteolysis and HypercalcemiaPublished by Springer Nature ,1989
- Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronateBone, 1988
- Diphosphonate therapy in hypercalcemia of malignancy and tumoral osteolysisTrends in Pharmacological Sciences, 1984
- Long Term Effects of Dichloromethylene Diphosphonate in Paget's Disease of BoneJournal of Clinical Endocrinology & Metabolism, 1982
- Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple MyelomaMetabolic Bone Disease and Related Research, 1982
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980